Biotech

All Articles

ArsenalBio elevates $325M, turns out of past lead possession

.Arsenal Biosciences is moving on up. The cell treatment company has actually added $325 thousand in...

Lilly- backed weight loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...

Aelis' cannabis use drug flunks phase 2b, steering Indivior to review $100M option

.Aelis Farma's chances of protecting a simple, beneficial decision on a $one hundred million alterna...

ProKidney halts period 3 test certainly not required for cell treatment authorization

.ProKidney has quit among a set of phase 3 tests for its cell therapy for renal ailment after choosi...

Vaxcyte surges on 'remarkable' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts called "remarkable" period 1/2 records for its own 31-valent pneumo...

Recursion's mind illness test reveals insufficient proof of efficacy

.Recursion has discovered through an early test of its own tech-enabled strategy to medicine explora...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Call it a scenario of good chemistry: Acepodia, a biotech based upon Nobel Champion scientific rese...

Praxis epilepsy drug lowers seizures in period 2 hearing

.Practice Preciseness Medicines has racked up yet another midphase succeed in epilepsy this year, al...

Three execs resign as Dyne messages blended records for DMD applicant

.After escaping a professional hold a number of years back, Dyne Therapeutics has uncovered new phas...

Arrowhead fires off phase 3 records in unusual metabolic illness in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give in advance of a potential face-off alo...